| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eton Pharmaceuticals, Inc. (ETON) has 8 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ETON is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.05M | $99.71M | - | |
| Other | 630.2K | $20.62M | - | |
| Dir | 295.2K | $9.66M | - | |
| Dir | 286.5K | $9.37M | - | |
| Dir | 286.5K | $9.37M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2020 | Opaleye Management Inc.60 | 10% Owner | Buy | 400,000 | $7.00 | $2,800,000.00 | +11.0% | |
| Aug 13, 2019 | Brynjelsen Sean | President &CEO | Buy | 5,000 | $6.15 | $30,750.00 | +0.5% | |
| Aug 9, 2019 | Casamento Charles J71 | Director | Buy | 3,500 | $6.11 | $21,369.95 | +5.1% | |
| May 21, 2019 | Brynjelsen Sean | President &CEO | Buy | 10,000 | $7.93 | $79,325.86 | +0.5% | |
| Nov 15, 2018 | Brynjelsen Sean | President &CEO | Buy | 10,000 | $6.00 | $60,000.00 | +1.0% | |
| Nov 15, 2018 | Troutman William Wilson | CFO, Treasurer &Secretary | Buy | 5,000 | $6.00 | $30,000.00 | New | |
| Nov 15, 2018 | Maier Paul V | Director | Buy | 5,000 | $6.00 | $30,000.00 | +9.1% | |
| Nov 15, 2018 | Riedel Norbert G63 | Director | Buy | 5,000 | $6.00 | $30,000.00 | +9.1% | |
| Nov 15, 2018 | Baum Mark L66 | Director | Buy | 10,000 | $6.00 | $60,000.00 | New | |
| Nov 15, 2018 | Casamento Charles J71 | Director | Buy | 5,000 | $6.00 | $30,000.00 | +7.9% |